Clinical trial
Miltefosine Combined With Intralesional Pentamidine for Leishmania Braziliensis Cutaneous Leishmaniasis in Bolivia
NCT03445897 is registered in ClinicalTrials.gov with Jonathan Berman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Miltefosine Combined With Intralesional Pentamidine for Leishmania Braziliensis Cutaneous Leishmaniasis in Bolivia
- Lead sponsor
- Jonathan Berman
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- February 21, 2018
- Enrollment
- 50 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.